Krebs Biochemicals Files Annual Report for FY26

Krebs Biochemicals & Industries Ltd has filed its Annual Report for the financial year ended March 31, 2026. The report includes a five-year highlight of key financial metrics. For FY26, the company reported Total Income of ₹2,575.79 Lakhs, a Profit/(Loss) Before Tax of ₹(1,693.31) Lakhs, and a Profit/(Loss) After Tax of ₹(1,693.31) Lakhs. Reserves and Surplus stood at ₹(18,431.53) Lakhs, leading to a Net Worth of ₹(16,275.47) Lakhs. Earnings Per Share (EPS) was ₹(85) and Book Value Per Share was ₹(75.49). The report also details corporate information, directors, key managerial personnel, registered office, plant locations, and statutory auditors.